drug incorporation into an amphiphilic polymer micelle ... · analyses of the absolute forward saxs...

4
2009A1883 BL40B2 Drug Incorporation into an Amphiphilic Polymer Micelle Explored with Synchrotron SAXS a a a a a a a a a a b b Isamu Akiba a , Naotaka Terada a , Satoshi Hashida a , Yusuke Akino a , Kohei Kamemoto a , Hiroyasu Masunaga b , Kazuo Sakurai a a b /SPring-8 a The University of Kitakyushu, b JASRI/SPring-8 -b- ( , - -L- )(PEG-PBLA) (LE540) X (SAXS) LE540 PBLA LE540 LE540 Incorporation of hydrophobic drug (LE540) into a micelle consisting of poly(ethylene glycol)-block- -benzyl-L-aspartate) (PEG-PBLA) was explored with synchrotron small-angle X-ray scattering (SAXS) measurements in vacuo. ecause the diffraction peak attributed to long period of PBLA in hydrophobic core was vanished by adding LE540, the hydrophobic drug is incorporated into hydrophobic core of the PEG-PBLA micelle with core-shell architecture. Analyses of the absolute forward SAXS intensity and by fitting with theoretical model revealed that incorporation of LE540 into the hydrophobic core induced drastic reduction of the scattering-length density, volume expansion of the core and increment of aggregation number without any changes of solvation of hydrophilic PEG chain. [1] DDS [2] DDS DDS DDS ( ) DDS DDS X (SAXS) -b- (, - - L- )(PEG-PBLA) [3]

Upload: others

Post on 24-Oct-2020

2 views

Category:

Documents


0 download

TRANSCRIPT

  • 2009A1883 BL40B2

    Drug Incorporation into an Amphiphilic Polymer Micelle Explored with Synchrotron SAXS

    aa aa aa aa aa b b

    Isamu Akibaa, Naotaka Teradaa, Satoshi Hashidaa, Yusuke Akinoa, Kohei Kamemotoa, Hiroyasu Masunagab,

    Kazuo Sakuraia

    a b /SPring-8 aThe University of Kitakyushu, bJASRI/SPring-8

    -b- ( , - -L- )(PEG-PBLA)(LE540) X (SAXS)

    LE540 PBLALE540

    LE540

    Incorporation of hydrophobic drug (LE540) into a micelle consisting of poly(ethylene glycol)-block--benzyl-L-aspartate) (PEG-PBLA) was explored with synchrotron small-angle X-ray scattering (SAXS)

    measurements in vacuo. ecause the diffraction peak attributed to long period of PBLA in hydrophobic core was vanished by adding LE540, the hydrophobic drug is incorporated into hydrophobic core of the PEG-PBLA micelle with core-shell architecture. Analyses of the absolute forward SAXS intensity and by fitting with theoretical model revealed that incorporation of LE540 into the hydrophobic core induced drastic reduction of the scattering-length density, volume expansion of the core and increment of aggregation number without any changes of solvation of hydrophilic PEG chain.

    [1]

    DDS[2]

    DDS

    DDS DDS

    ()

    DDS DDS

    X(SAXS)

    -b- ( , - -L-)(PEG-PBLA) [3]

    �����

  • LE540Scheme 1 LE540

    PEG-PBLA THFTHF

    PEG-PBLA/LE540

    25mg/ml

    1/40

    PEG-PBLA LE540 (LLE540) 01.3 3.0 5.8 8.3 wt%

    SAXSSAXS SPring-8 BL-40B2

    30cm×30cm(RIGAKU R-AXIS VII)

    1.8m 0.7 m 1.0S/N

    2SAXS 1 SAXS

    (I(q) vs. q) I(q) qq

    Glatter

    [4]

    CH3O CH2CH2O CH2 NH COCHNH

    CH2COOR

    COCH2CHNH

    COOR

    Hn

    ma b3

    n=117, m=24, a : b=1 : 3, Degree of benzyl substitution: 82.6%

    CH2R = H or

    (a) PEG-PBLA

    N

    N

    H3C

    COOH

    (b) LE540

    Scheme 1

    Fig. 1 LE540 PEG-PBLAX

    4 nm-1

    PBLALLE540

    LLE540 5.8 wt%

    LE540 PBLALE540 PBLA

    Fig. 1. MAXS profiles of PEG-PBLA micelles loaded with LE540.

    Fig. 2Guinier (ln[I(q)] vs. q2)

    LLE540LLE540 3.0 wt%

    (I(0)) LLE540LLE540 3.0 wt% I(0)LLE540

    GuinierI(q) q [5]

    2 2( ) (0)exp( / 3)gI q I q R (1)

    I(0) q=0 RgLLE540

    3.0 wt% Rg LLE540

    �����

  • 3.0 wt% Rg LLE540I(0)

    ( )

    2 20(0) ( )MI NV

    (2)

    0

    VM NPBLA

    LE540LLE540

    LLE540 I(0)VM

    LLE540 RgI(0) LE540

    PEG-PBLA

    -6.0

    -5.0

    -4.0

    -6.0

    -5.0

    -4.0

    0.080.060.040.020.00

    q2/nm-2

    ln[I(

    q)]

    Fig. 2. Guinier plots of PEG-PBLA micelles loaded with LE540. a) LLE540 = 0, and 1.4 wt%, b) LLE540 = 3.0, 5.8, and 8.3 wt%

    2

    32

    0 3

    3 sin( ) cos( )( )

    ( )( )

    3 sin( ) cos( )( )

    ( )

    C c CCC S

    M CM

    S S SS

    S

    qR qR qRVV qR

    I q NVqR qR qR

    qR(3)

    C S

    ( ) RC RS

    SAXS

    4

    GuinierRg

    2 22

    3 ( )5 ( )C C C S S S S

    gC C S S S

    V R V RR

    V V (4)

    (4) (2)2 PBLA

    PEGPEG

    PEG2

    10-7

    10-6

    10-5

    10-4

    10-3

    10-2

    10-1

    I(q)/c

    m-1

    6 7 8 90.1

    2 3 4 5 6 7 8 91

    2

    q/nm-1

    Rc = 6.9 nm, Rs = 12.8 nm,

    c = 437 e/nm3, s = 339 e/nm

    3

    /Rs = 0.15

    b)

    �����

  • Fig. 3. SAXS profiles of the PEG-PBLA micelle with LE540 content of 8.3 wt% for PEG-PBLA. Solid lines are theoretical curves of the core-shell model taking the size distribution into account.

    Fig.3 LLE540=8.3 wt%SAXS

    Table 1Fig. 3 Rc LLE540

    Fig. 4Nagg

    PBLA c Aagg

    PBLA PBLA

    x V NNM

    MPBLA PBLA PBLAPBLA Vc PBLA

    PBLATable 1 ( )

    LLE540

    PBLA LLE5403.0 5.8 wt%

    PBLA

    Fig. 4 PBLA

    LE540LE540

    PBLAPEG-PBLA

    Table 1 Characteristic parameters for PEG-PBLA/LE540 micelles resulted from fitting analyses using core-shell sphere model.

    LLE540/wt% for

    PEG-PBLA RC/nm RS /nm c /cm-2 s /cm-2

    0 5.9 12.5 1.38 1011 9.58 1010

    1.4 5.9 12.5 1.35 1011 9.58 10103.0 6.1 12.3 1.28 1011 9.55 1010

    5.8 6.7 12.5 1.25 1011 9.55 10108.3 6.9 12.5 1.23 1011 9.55 1010

    Fig. 4. Plots of Rc and aggregation number of PEG-PBLA for a micelle against LLE540.

    1. Zhang, L. F.; Eisenberg, A. Science 1995, 268,1728-1731.

    2. Kakizawa, K.; Kataoka, K. Adv. Drug Delivery Rev. 2002, 54, 203-222.

    3. Yokoyama, M.; Opanasopit, P.; Okano, T.; Kawano, K.; Maitani, Y. J. Drug Targeting2004, 12, 373-384.

    4. Orthaber, D.; Bergmann, A.; Glatter, O. J. Appl. Cryst. 2000, 33, 218-225.

    5. Feigin, L. A.; Svergun, D. I. Structure Analysis by Small-angle X-ray and Neutron Scattering; Plenum Press: New York, 1987.

    11 SAS2009, Oxford, UK

    Polymeric micelle, DDS, SAXS, Core-shell model

    �����

    0000表紙.pdf0000目次0001概要0002本文0003表3